3349.T

Stock Details

3349.T is COSMOS Pharmaceutical Corporation's stock. Stock exchange Tokyo (Currency JPY). Average price in 50 days is 11,864.60￥. Average daily volumn in 3 months 309.44k. Market cap 515.98B

Stock symbol : 3349.T. Exchange : Tokyo. Currency : JPY
Lastest price : 13,030.00￥. Total volume : 185.80k. Market state POSTPOST
Click reload if you want to check the lastest price on market!!!

COSMOS Pharmaceutical Corporation (3349.T)

Last Price

13,030.00￥

Change

-150.00

Volume

185.80k


Previous Close	13,180.00
Open	12,910.00
Day Range	12,850.00-13,130.00
Bid	13,010.00 x N/A
Ask	13,040.00 x N/A
Volume	185.8k
Average Volume	309.44k


Market Cap	515.98B
Beta	0.35
52 Week Range	10,770.00-20,700.00
Trailing P/E	23.42
Foward P/E	21.08
Dividend (Yield %)	0.68%
Ex-Dividend Date	2022-05-30

Financial Details

According to COSMOS Pharmaceutical Corporation's financial reports the company's revenue in 2021 were 726.42B an increase( +6.14%) over the years 2020 revenue that were of 684.4B. In 2021 the company's total earnings were 27.16B while total earnings in 2020 were 21.43B( +28.57%).

Loading ...

Organization

COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. It also operates 1,130 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was founded in 1983 and is headquartered in Fukuoka, Japan.

Market Cap:

515.98B

Revenue:

726.42B

Total Assets:

341.32B

Total Cash:

55.11B

News about "COSMOS Pharmaceutical Corporation"

Cosmos Pharmaceutical Corp (3349)

Source from : Investing.com - 6 days ago

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...See details»

COSMOS Pharmaceutical Corp - Stock Trailing Returns 3349

Source from : Morningstar%2c Inc. - 13 days ago

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...See details»

Cosmo Pharmaceuticals (OTC:CMOPF) Coverage Initiated by Analysts at Credit Suisse Group

Source from : Defense World - 6 days ago

Credit Suisse Group assumed coverage on shares of Cosmo Pharmaceuticals (OTC:CMOPF – Get Rating) in a report published on Thursday morning, The Fly reports. The brokerage issued an outperform rating ...See details»

Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon in the United States

Source from : Digital Journal - 28 days ago

About Cosmos Holdings, Inc. Cosmos Holdings Inc. (Nasdaq:COSM) is an international pharmaceutical company, with a proprietary line of nutraceuticals and distributor of branded and generic ...See details»

Cosmo Pharmaceuticals Shareholders approve all Agenda Items at Annual General Meeting FOR ELEVIEW® TO ALL COUNTRIES EXCEPT CANADA

Source from : Business Insider - 1 month ago

Cosmo Pharmaceuticals Shareholders approve all Agenda Items at Annual General Meeting FOR ELEVIEW® TO ALL COUNTRIES EXCEPT CANADA 27.05.2022 / 15:15 Press Release (PDF) Dublin, Ireland 27 May ...See details»

CMOPF Cosmo Pharmaceuticals N.V.

Source from : Seeking Alpha - 16 days ago

The chart has 1 X axis displaying Time. Data ranges from 2021-06-14 00:00:00 to 2022-06-14 10:00:18. The chart has 1 Y axis displaying symbol price. Data ranges from 47.5 to 98.See details»

Medtronic Displays its GI Genius at UEG Week

Source from : MD&M East - 13 days ago

The Dublin-based company is launching GI Genius – a system it said ... GI Genius was developed by Cosmo Pharmaceuticals and has CE mark. Medtronic is bringing the solution to the market through a ...See details»

Cosmo announces acceptance of NDA submission of Cortiment® MMX® in Japan

Source from : dgap - 2 days ago

Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) announced that Ferring, our partner for Cortiment® MMX® (budesonide), submitte ...See details»

Pharmacies and Healthcare Stores Global Market Report 2022: A $1.67 Billion Market in 2026 - Forecast to 2031 - ResearchAndMarkets.com

Source from : The Register-Herald - 20 days ago

Costco Wholesale Corp, Loblaw, George Weston ltd, TSURUHA Holdings Inc., COSMOS Pharmaceutical Corporation, and Welcia Holdings Co. Ltd. The pharmacies and healthcare stores market consists of ...See details»

LAB n PEOPLE Corp., which developed the world’s first ‘Magnesium Microneedle’ Participating in Las Vegas Cosmoprof Exhibition 2022

Source from : Digital Journal - 13 days ago

Last year, starting with the joint development of pharmaceuticals between Daewoong Pharmaceutical Corp., the largest pharmaceutical company in Korea, and Microneedle, a Contract on Product Supply ...See details»

Synthetic Paper Market Impressive Growth, Trends, Share, Top Key Players Analysis and Forecast 2029

Source from : MarketWatch - 28 days ago

drive the product application in various end-use industries like food and beverages, pharmaceuticals, etc. Fortune Business Insights™ has presented this information in an upcoming report titled ...See details»

COSMOS Pharmaceutical Corp - Stock Executive 3349

Source from : Morningstar%2c Inc. - 22 days ago

Cosmo Pharmaceuticals (OTC:CMOPF) Coverage Initiated by Analysts at Credit Suisse Group

Source from : ETF Daily News - 6 days ago

Cosmo Pharmaceuticals has a 12 month low of 47.50 and a 12 month high of 74.00. Get Cosmo Pharmaceuticals alerts: Cosmo Pharmaceuticals Company Profile ( Get Rating ) ...See details»